Position in SKYE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$0
-$13 QoQ
Shares Held
1
-94.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NFSG Corp holds $2,980,656 across 44 Biotechnology names. SKYE ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,478 | $1,820,628 | |
| 2 | OMER |
Omeros Corp
|
47,710 | $503,817 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
9,425 | $120,828 | |
| 4 | MRNA |
Moderna, Inc.
|
2,200 | $111,760 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
66 | $50,994 | |
| 6 | GLSI |
Greenwich LifeSciences, Inc.
|
2,100 | $50,442 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
1,003 | $40,430 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
1,200 | $39,048 |
All Filings in SKYE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0 | 1 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $13 | 18 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $70 | 18 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $75 | 18 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $28 | 18 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50 | 18 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $70 | 18 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $144 | 18 | Shares | Sole | 2024-09-11 | |
| No filing history on record for this holder in this stock. | ||||||